Arterial Inflammation and E-Cigarettes

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02734888

Enrollment

Registered

2016-04-12

Start date

2015-07-31

Completion date

2023-02-01

Last updated

2023-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Inflammation

Keywords

arterial inflammation, electronic cigarettes, PET scan

Brief summary

Arterial inflammation will be compared using PET scanning in 3 groups: 1) Non-smokers, 2) Tobacco cigarette smokers, 3) Electronic cigarette users.

Detailed description

Qualified participants will undergo a singe PET/CT to detect arterial inflammation.

Interventions

OTHERNo drug or device, only a test. The test is called a PET/CT

A single PET/CT scan will be performed

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

21 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

Healthy * Nonsmokers OR * Daily e-cigarette user OR * Daily tobacco cigarette smoker

Exclusion criteria

* Cardiac disease * Respiratory Disease * Diabetes mellitus

Design outcomes

Primary

Measure	Time frame	Description
target-to-background ratio (TBR)	intraoperative	TBR will be detected on the scan

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026